Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00XKH
|
|||
Former ID |
DNC004372
|
|||
Drug Name |
S-(N-butyl-N-hydroxycarbamoyl)glutathione
|
|||
Synonyms |
CHEMBL128447; S-(N-butyl-N-hydroxycarbamoyl)glutathione; SCHEMBL3281791; BDBM50092822
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C15H26N4O8S
|
|||
Canonical SMILES |
CCCCN(C(=O)SCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N)O
|
|||
InChI |
1S/C15H26N4O8S/c1-2-3-6-19(27)15(26)28-8-10(13(23)17-7-12(21)22)18-11(20)5-4-9(16)14(24)25/h9-10,27H,2-8,16H2,1H3,(H,17,23)(H,18,20)(H,21,22)(H,24,25)/t9-,10-/m0/s1
|
|||
InChIKey |
JHOFGABPPOTPEX-UWVGGRQHSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Lactoylglutathione lyase (GLO1) | Target Info | Inhibitor | [1] |
BioCyc | Methylglyoxal degradation I | |||
KEGG Pathway | Pyruvate metabolism | |||
NetPath Pathway | TCR Signaling Pathway | |||
Pathwhiz Pathway | Pyruvaldehyde Degradation | |||
Pyruvate Metabolism | ||||
Reactome | Pyruvate metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | Role of hydrophobic interactions in binding S-(N-aryl/alkyl-N-hydroxycarbamoyl)glutathiones to the active site of the antitumor target enzyme glyoxalase I. J Med Chem. 2000 Oct 19;43(21):3981-6. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.